Despite the Trump administration's shake-up of the agency, the US FDA is the first port of call for most ASX biotechs.

Obstructive sleep apnea or OSA affects nearly a billion people across the globe. It robs people of their sleep.

With restaurants, stadiums, and hospitality venues aiming to adopt greener practices, ReRoute Americas emerges as a trusted sustainability partner.

When it comes to split ends and frayed strands, lots of us want a savior to quickly fix damaged hair—one that doesn’t require ...

If reviews of the best hypochlorous acid spray hasn’t popped up on your SkinTok feed yet, trust us—it’s only a matter of time ...

Firstsource Solutions Ltd today announced its inclusion in the prestigious S&P Global Sustainability Yearbook for the second ...

Indegene, a digital-first life sciences commercialization company, today announced the launch of a new center in London.

The S&P/ASX 200 closed 32.1 points lower, down 0.41%. Uranium stocks saw another steady day of gains today as the uranium ...

"Astellas stands by the clinical profile of Izervay, the only FDA-approved GA treatment that consistently demonstrated statistically significant slowing of GA across two pivotal Phase 3 studies ...